AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Medicine | Publishing Language: Chinese | Open Access

Effect of first-day fluid intake after transferring to ICU on 7-day risk for death in patients with chronic liver disease after surgery: a retrospective cohort study based on MIMIC-Ⅳ database

Zhuo ZHANChunyong YANGXin SHUYiziting ZHUKaizhi LU( )Jianliang SHAO( )
Department of Anesthesiology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China
Show Author Information

Abstract

Objective

Patients with chronic liver diseases often exhibit unique hemodynamic abnormalities and metabolic disorders. Postoperative fluid management presents numerous challenges, especially for critically ill patients admitted to the intensive care unit (ICU) after surgery. This study aimed at exploring the relationship between postoperative fluid therapy and prognosis.

Methods

Based on 2414 patients with chronic liver diseases who underwent surgical treatment and were subsequently transferred to the ICU in the MIMIC-Ⅳ database, a retrospective cohort study was conducted on the final 2143 patients after our inclusion and exclusion criteria. Multivariate adjusted logistic regression model was used to analyze the association between fluid therapeutic regimens on the first day after ICU admission and the risk of 7-day death after surgery. Restricted cubic spline (RCS) was applied to analyze the dose-response relationship.

Results

Multivariate analysis indicated that restrictive fluid resuscitation was an independent protective factor. Compared with the non-restrictive fluid resuscitation group, restrictive fluid resuscitation significantly reduced the 7-day postoperative mortality rate (6.4% vs 12.4%, OR=0.44, 95%CI: 0.22~0.88, P=0.021), decreased the use of mechanical ventilation (42.9% vs 72.3%, OR=0.29, 95%CI: 0.24~0.35, P<0.001), and shortened the ICU stay (1.86 vs 3.47 d, OR=0.81, 95%CI: 0.78~0.84, P<0.001). RCS curve showed that the fluid intake on the first postoperative day and the 7-day postoperative mortality risk presented a J-shaped curve relationship, with an inflection point at 1850 mL. Beyond this threshold, the 7-day postoperative mortality risk was increased. Subgroup analysis results indicated that the protective effect of restrictive fluid resuscitation was consistent across different age and comorbidity groups.

Conclusion

For patients with chronic liver diseases, adopting a restrictive fluid therapy on the first day after surgery can effectively reduce the risk of short-term death. Moreover, there is a non-linear dose-effect relationship between the fluid intake and the 7-day mortality risk. When the fluid intake exceeds 1850 mL, the risk of death significantly increases.

CLC number: R181.32; R472.9; R575 Document code: A

References

【1】
【1】
 
 
Journal of Army Medical University
Pages 1931-1939

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHAN Z, YANG C, SHU X, et al. Effect of first-day fluid intake after transferring to ICU on 7-day risk for death in patients with chronic liver disease after surgery: a retrospective cohort study based on MIMIC-Ⅳ database. Journal of Army Medical University, 2025, 47(16): 1931-1939. https://doi.org/10.16016/j.2097-0927.202507027

141

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 07 July 2025
Revised: 28 July 2025
Published: 30 August 2025
© 2025 Journal of Army Medical University

This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).